Published on
May 29, 2020
- 05:00 GMT
Santhera Provides Update on the Ongoing Regulatory Review of Puldysa® (Idebenone) by the CHMP in Duchenne Muscular Dystrophy (DMD)
A conference call will be held today at 13:00 CEST, 12:00 BST, 07:00 EDT. Details are at the end of this statement. Pratteln, Switzerland, May 29, 2020 – Santhera Pharmaceuticals (SIX: SANN) announces that the EMA’s CHMP has granted a requested extension …
Distribution channels:
Technology
